Fatostatin A

Modify Date: 2024-01-30 20:50:37

Fatostatin A Structure
Fatostatin A structure
Common Name Fatostatin A
CAS Number 125256-00-0 Molecular Weight 294.41400
Density N/A Boiling Point N/A
Molecular Formula C18H18N2S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Fatostatin A


Fatostatin A is a inhibitor of SREBP that directly binds SCAP and blocks its ER-to-Golgi transport with IC50 of 2.5 and 10 μM in mammalian cellstarget: SREBPIC50: 2.5 ~10 μMIn vitro: Fatostatin A suppress cell proliferation and anchorage-independent colony formation in both androgen-responsive LNCaP and androgen-insensitive C4-2B prostate cancer cells. [1] Fatostatin potently inhibited cell growth.[2]In vivo: Fatostatin A cause G2/M cell cycle arrest and induce apoptosis by increasing caspase-3/7 activity and the cleavages of caspase-3 and PARP. [1] μCT analyses show that fatostatin A treatment preserve bone mass and structure in the proximal tibial trabecular bone in the mouse RANKL-induced bone loss model.[3]

 Names

Name 4-[4-(4-Methylphenyl)-1,3-thiazol-2-yl]-2-propylpyridine
Synonym More Synonyms

 Fatostatin A Biological Activity

Description Fatostatin A is a inhibitor of SREBP that directly binds SCAP and blocks its ER-to-Golgi transport with IC50 of 2.5 and 10 μM in mammalian cellstarget: SREBPIC50: 2.5 ~10 μMIn vitro: Fatostatin A suppress cell proliferation and anchorage-independent colony formation in both androgen-responsive LNCaP and androgen-insensitive C4-2B prostate cancer cells. [1] Fatostatin potently inhibited cell growth.[2]In vivo: Fatostatin A cause G2/M cell cycle arrest and induce apoptosis by increasing caspase-3/7 activity and the cleavages of caspase-3 and PARP. [1] μCT analyses show that fatostatin A treatment preserve bone mass and structure in the proximal tibial trabecular bone in the mouse RANKL-induced bone loss model.[3]
Related Catalog
References

[1]. Li X et al. Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling. Mol Cancer Ther. 2014 Apr;13(4):855-66.

[2]. Shao W et al. Fatostatin blocks ER exit of SCAP but inhibits cell growth in a SCAP-independent manner. J Lipid Res. 2016 Aug;57(8):1564-73.

[3]. Inoue K et al. Fatostatin, an SREBP inhibitor, prevented RANKL-induced bone loss by suppression of osteoclast differentiation. Biochim Biophys Acta. 2015 Nov;1852(11):2432-41.

 Chemical & Physical Properties

Molecular Formula C18H18N2S
Molecular Weight 294.41400
Exact Mass 294.11900
PSA 54.02000
LogP 5.13300
Storage condition 2-8℃

 Safety Information

HS Code 2934100090

 Customs

HS Code 2934100090
Summary 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%

 Synonyms

Hexatype Brown N
Typogen Brown N
Resinol RRN
Solvent Brown 1
fatostatin A
Sudan Brown YR
Sudan Brown RR
Fat Brown RR
1-naphthylamin->m-phenylendiamin
C.I. Solvent Brown 1
4-naphthalen-1-yl-diazenyl-benzene-1,3-diamine
Lithofor Brown A
Top Suppliers:I want be here




Get all suppliers and price by the below link:

Fatostatin A suppliers


Price: $79/10mM*1mLinDMSO

Reference only. check more Fatostatin A price